Sign In
Buy GKOS
$113.64
+2.86 (+2.58%)
At Close: Jun 03, 2026
Tudor Investment Corp Et Al Invests $613,000 in Glaukos Corp (NYSE:GKOS)
06:50am, Tuesday, 15'th Sep 2020
Tudor Investment Corp Et Al acquired a new position in shares of Glaukos Corp (NYSE:GKOS) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired
Glaukos Is Still A Good Long-Term Value Despite A Tough 2020
08:04am, Thursday, 20'th Aug 2020
Glaukos' results went from bad to worse in Q2 as the pandemic continued to delay elective procedures like the cataract surgeries during which the company's stents are placed.
Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Glaukos Corporation (NYSE: GKOS) ("Glaukos" or the "Company") for violations of federal securities laws.
Glaukos (GKOS) Loses 17.1% Despite Q2 Earnings & Revenues Beat
11:10am, Wednesday, 12'th Aug 2020
Glaukos' (GKOS) second-quarter results reflect fall in revenues partially mitigated by contribution from Avedro buyout.
Raymond James Financial Services Advisors Inc. Purchases Shares of 6,421 Glaukos Corp (NYSE:GKOS)
10:56am, Tuesday, 11'th Aug 2020
Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Glaukos Corp (NYSE:GKOS) during the second quarter, according to the company in its most recent 13F filing with the Se
Orbimed Advisors reduced stake in Inspire Medical Systems Inc.
12:00am, Tuesday, 11'th Aug 2020
Orbimed Advisors reduced stake in Inspire Medical Systems Inc.
Is Glaukos (NYSE:GKOS) A Risky Investment?
05:25pm, Monday, 10'th Aug 2020
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
01:00am, Friday, 07'th Aug 2020
Glaukos (GKOS) delivered earnings and revenue surprises of 21.79% and 55.92%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
The Global Glaucoma Surgery Devices Market will grow by USD 1.53 bn during 2020-2024
Glaukos Corporation Announces Second Quarter 2020 Financial Results
08:10pm, Thursday, 06'th Aug 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today an
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Envestnet Asset Management Inc. Reduces Position in Glaukos Corp (NYSE:GKOS)
05:06am, Monday, 03'rd Aug 2020
Envestnet Asset Management Inc. lessened its holdings in shares of Glaukos Corp (NYSE:GKOS) by 54.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commis
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
